Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines. (2021)
Attributed to:
Dissecting the molecular pathways of MDV oncoprotein Meq for understanding pathogenesis and aid vaccine development
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1089/crispr.2021.0017
PubMed Identifier: 34406035
Publication URI: http://europepmc.org/abstract/MED/34406035
Type: Journal Article/Review
Volume: 4
Parent Publication: The CRISPR journal
Issue: 4
ISSN: 2573-1599